Jump to:

Zocor for heterozygous familial hypercholesterolaemia

27 May 2010, 10:06am

Be the first to comment

Zocor for heterozygous familial hypercholesterolaemia

The licence for Zocor (simvastatin) has been extended to include use in children and adolescents, 10-17 years of age, with heterozygous familial hypercholesterolaemia.

Boys should be Tanner stage II and above and girls at least 1 year post menarche.

A standard cholesterol-lowering diet should be started before treatment with simvastatin is initiated and continued during treatment.

View Zocor drug record

Further information: MSD

All Comments

There are currently no comments.

You must log in to comment on articles.

New users can register here free for full access.

You must log in to make full use of all the site content and features.

New users can register here free for full site access.

Related Drug Categories

 

GP Curriculum Centre

Educational resource for the learning and teaching of the
GP curriculum

Click here to read more

Deleted products

Cumulative list of products discontinued from the UK market
in 2010

Click here to read more

Treating psoriasis

Healthcare Republic resource centre for diagnosing and managing psoriasis

Click here to read more

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

 

Back to top